Download Files:
Bexirestrant
SKU
HY-145556-Get quote
Category Reference compound
Tags Cancer, Estrogen Receptor/ERR, Vitamin D Related/Nuclear Receptor
Products Details
Product Description
– Bexirestrant is an orally active ER-α degrader. Bexirestrant can be used for the research of antiestrogen, antineoplastic[1][2].
Web ID
– HY-145556
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C29H26F3NO2
References
– [1]Ranjan Kumar Pal, et al, Selective estrogen receptor degrader. WO2021014386 A1.|[2]WHO Drug Information, Vol. 35, No. 4, 2021. Geneva: World Health Organization; 2022.
CAS Number
– 2505067-70-7
Molecular Weight
– 477.52
SMILES
– CC1=C(C2=CC(F)=CC(F)=C2)[C@H](C3=CC=C(C=C3)/C=C/CN4CC(C4)CF)OC5=CC(O)=CC=C51
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Estrogen Receptor/ERR
Pathway
– Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.